Pregnane	O
X	O
Receptor	O
Represses	O
HNF4alpha	O
Gene	O
to	O
Induce	O
Insulin	O
-	O
Like	O
Growth	O
Factor	O
-	O
Binding	O
Protein	O
IGFBP1	O
that	O
Alters	O
Morphology	O
of	O
and	O
Migrates	O
HepG2	O
Cells	O
.	O


Upon	O
treatment	O
with	O
the	O
pregnane	O
X	O
receptor	O
(	O
PXR	O
)	O
activator	O
rifampicin	O
(	O
RIF	O
)	O
,	O
human	O
hepatocellular	O
carcinoma	O
HepG2	O
-	O
derived	O
ShP51	O
cells	O
that	O
stably	O
express	O
PXR	O
showed	O
epithelial	O
-	O
mesenchymal	O
transition	O
(	O
EMT	O
)	O
-	O
like	O
morphological	O
changes	O
and	O
migration	O
.	O


Our	O
recent	O
DNA	O
microarrays	O
have	O
identified	O
hepatocyte	O
nuclear	O
factor	O
(	O
HNF	O
)	O
4alpha	O
and	O
insulin	O
-	O
like	O
growth	O
factor	O
-	O
binding	O
protein	O
(	O
IGFBP	O
)	O
1	O
mRNAs	O
to	O
be	O
downregulated	O
and	O
upregulated	O
,	O
respectively	O
,	O
in	O
RIF	O
-	O
treated	O
ShP51	O
cells	O
,	O
and	O
these	O
regulations	O
were	O
confirmed	O
by	O
the	O
subsequent	O
real	O
-	O
time	O
polymerase	O
chain	O
reaction	O
and	O
Western	O
blot	O
analyses	O
.	O


Using	O
this	O
cell	O
system	O
,	O
we	O
demonstrated	O
here	O
that	O
the	O
PXR	O
-	O
HNF4alpha	O
-	O
IGFBP1	O
pathway	O
is	O
an	O
essential	O
signal	O
for	O
PXR	O
-	O
induced	O
morphological	O
changes	O
and	O
migration	O
.	O


First	O
,	O
we	O
characterized	O
the	O
molecular	O
mechanism	O
underlying	O
the	O
PXR	O
-	O
mediated	O
repression	O
of	O
the	O
HNF4alpha	O
gene	O
.	O


Chromatin	O
conformation	O
capture	O
and	O
chromatin	O
immunoprecipitation	O
(	O
ChIP	O
)	O
assays	O
revealed	O
that	O
PXR	O
activation	O
by	O
RIF	O
disrupted	O
enhancer	O
-	O
promoter	O
communication	O
and	O
prompted	O
deacetylation	O
of	O
histone	O
H3	O
in	O
the	O
HNF4alpha	O
P1	O
promoter	O
.	O


Cell	O
-	O
based	O
reporter	O
and	O
ChIP	O
assays	O
showed	O
that	O
PXR	O
targeted	O
the	O
distal	O
enhancer	O
of	O
the	O
HNF4alpha	O
P1	O
promoter	O
and	O
stimulated	O
dissociation	O
of	O
HNF3beta	O
from	O
the	O
distal	O
enhancer	O
.	O


Subsequently	O
,	O
small	O
interfering	O
RNA	O
knockdown	O
of	O
HNF4alpha	O
connected	O
PXR	O
-	O
mediated	O
gene	O
regulation	O
with	O
the	O
PXR	O
-	O
induced	O
cellular	O
responses	O
,	O
showing	O
that	O
the	O
knockdown	O
resulted	O
in	O
the	O
upregulation	O
of	O
IGFBP1	O
and	O
EMT	O
-	O
like	O
morphological	O
changes	O
without	O
RIF	O
treatment	O
.	O


Moreover	O
,	O
recombinant	O
IGFBP1	O
augmented	O
migration	O
,	O
whereas	O
an	O
anti	O
-	O
IGFBP1	O
antibody	O
attenuated	O
both	O
PXR	O
-	O
induced	O
morphological	O
changes	O
and	O
migration	O
in	O
ShP51	O
cells	O
.	O


PXR	O
indirectly	O
activated	O
the	O
IGFBP1	O
gene	O
by	O
repressing	O
the	O
HNF4alpha	O
gene	O
,	O
thus	O
enabling	O
upregulation	O
of	O
IGFBP1	O
to	O
change	O
the	O
morphology	O
of	O
ShP51	O
cells	O
and	O
cause	O
migration	O
.	O


These	O
results	O
provide	O
new	O
insights	O
into	O
PXR	O
-	O
mediated	O
cellular	O
responses	O
toward	O
xenobiotics	O
including	O
therapeutics	O
.	O
